108 related articles for article (PubMed ID: 19080492)
1. [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features].
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Hu XQ
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2833-7. PubMed ID: 19080492
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ
Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625
[TBL] [Abstract][Full Text] [Related]
3. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.
Qi L; Bart J; Tan LP; Platteel I; Sluis Tv; Huitema S; Harms G; Fu L; Hollema H; Berg Av
BMC Cancer; 2009 May; 9():163. PubMed ID: 19473551
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.
Chung MJ; Jung SH; Lee BJ; Kang MJ; Lee DG
Pathol Int; 2004 Jan; 54(1):10-5. PubMed ID: 14674989
[TBL] [Abstract][Full Text] [Related]
5. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of expression of PI3Kp110α in breast cancer].
Xiong Y; Si JW; Li D; Wang Y; Qu LL; Zhang H; Zhang B; Li T
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):743-749. PubMed ID: 27784457
[No Abstract] [Full Text] [Related]
7. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
[TBL] [Abstract][Full Text] [Related]
8. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
13. [PSCA expression in invasive micropapillary carcinoma of breast].
Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
[TBL] [Abstract][Full Text] [Related]
14. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
15. Expression of PTEN, cyclin D1, P27/KIP1 in invasive ductal carcinomas of the breast and correlation with clinicopathological parameters.
Engin H; Baltali E; Güler N; Güler G; Tekuzman G; Uner A
Bull Cancer; 2006 Feb; 93(2):E21-6. PubMed ID: 16517411
[TBL] [Abstract][Full Text] [Related]
16. MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.
Petrović N; Kolaković A; Stanković A; Lukić S; Řami A; Ivković M; Mandušić V
Cancer Biomark; 2016; 16(3):385-94. PubMed ID: 26889816
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Schwarzenbach H; Milde-Langosch K; Steinbach B; Müller V; Pantel K
Breast Cancer Res Treat; 2012 Aug; 134(3):933-41. PubMed ID: 22350790
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
[TBL] [Abstract][Full Text] [Related]
19. The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.
Lu YM; Cheng F; Teng LS
Sci Rep; 2016 Sep; 6():32723. PubMed ID: 27620353
[TBL] [Abstract][Full Text] [Related]
20. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
